Insiders · Profile

Chakma Justin

Chief Business Officer at ARS Pharmaceuticals. Filing since 25 Nov 2024. CIK 0001951238

Company

Date

Role

Action

Shares

Amount

Of holding

SPRY ARS Pharmaceuticals, Inc.

12 Nov 2025

Chief Business Officer

Sold at will

166,380

$1.48M

100%

SPRY ARS Pharmaceuticals, Inc.

13 Dec 2024

Chief Business Officer

Sold at will

27,272

$328.97K

16.7%

SPRY ARS Pharmaceuticals, Inc.

12 Dec 2024

Chief Business Officer

Sold at will

117,333

$1.44M

46.2%

SPRY ARS Pharmaceuticals, Inc.

10 Dec 2024

Chief Business Officer

Sold at will

50,000

$657.63K

26.8%

SPRY ARS Pharmaceuticals, Inc.

6 Dec 2024

Chief Business Officer

Sold at will

50,000

$711.62K

26.8%

SPRY ARS Pharmaceuticals, Inc.

5 Dec 2024

Chief Business Officer

Sold at will

49,640

$701.64K

26.7%

SPRY ARS Pharmaceuticals, Inc.

4 Dec 2024

Chief Business Officer

Sold at will

45,000

$627.94K

24.8%

SPRY ARS Pharmaceuticals, Inc.

3 Dec 2024

Chief Business Officer

Sold at will

45,000

$593.40K

24.8%

SPRY ARS Pharmaceuticals, Inc.

2 Dec 2024

Chief Business Officer

Sold at will

45,000

$615.22K

24.8%

SPRY ARS Pharmaceuticals, Inc.

27 Nov 2024

Chief Business Officer

Sold at will

25,000

$359.75K

15.5%

SPRY ARS Pharmaceuticals, Inc.

26 Nov 2024

Chief Business Officer

Sold at will

42,186

$592.57K

20.7%

SPRY ARS Pharmaceuticals, Inc.

25 Nov 2024

Chief Business Officer

Sold at will

32,814

$459.42K

13.9%

12 decisions on file.